Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Income Statement

Last quarter (Q4 2022), Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's total revenue was ¥2.69B, an increase of 72.71% from the same quarter last year. In Q4, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S's net income was ¥132.83M. See Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s key income statements, including revenue, expenses, profit, and income.